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Abstract
Background: Reasons for poor guideline adherence in acute gastroenteritis (AGE) in children in high-income
countries are unclear, but may be due to inconsistency between guideline recommendations, lack of evidence, and
lack of generalizability of the recommendations to general practice. The aim of this study was to assess the quality
of international guidelines on AGE in children and investigate the generalizability of the recommendations to
general practice.
Methods: Guidelines were retrieved from websites of professional medical organisations and websites of institutes
involved in guideline development. In addition, a systematic search of the literature was performed. Articles were
selected if they were a guideline, consensus statement or care protocol.
Results: Eight guidelines met the inclusion criteria, the quality of the guidelines varied. 242 recommendations on
diagnosis and management were found, of which 138 (57%) were based on evidence.
There is a large variety in the classification of symptoms to different categories of dehydration. No signs are
generalizable to general practice.
It is consistently recommended to use hypo-osmolar ORS, however, the recommendations on ORS-dosage are not
evidence based and are inconsistent. One of 14 evidence based recommendations on therapy of AGE is based on
outpatient research and is therefore generalizable to general practice.
Conclusions: The present study shows considerable variation in the quality of guidelines on AGE in children, as
well as inconsistencies between the recommendations. It remains unclear how to asses the extent of dehydration
and determine the preferred treatment or referral of a young child with AGE presenting in general practice.
Background
In acute gastroenteritis (AGE), a common childhood ill-
ness occurring worldwide, the most threatening compli-
cation is dehydration. In high-income countries,
implementation of oral rehydration therapy (ORT) has
not been as successful as in low-income countries[1,2].
In Dutch general practice, ORT is prescribed in only 4%
of children presenting with acute diarrhea [3]. It is
thought that too many children are referred to hospitals
and that a significant number of the hospital admissions
can be avoided [4,5]. There is a lack of evidence for the
use of antibiotics, antiemetics and antidiarrheals in
AGE, and serious side-effects of loperamide in young
children have been reported [6,7]. Nevertheless, of chil-
dren presenting with acute diarrhea in Dutch general
practice, 16% receive a prescription for antiemetics, anti-
biotics or antidiarrheals[3].
Implementation of a guideline on AGE management
in children can lead to a reduction in invasive proce-
dures and hospital admissions, and shorter hospital
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reports are available to assist in developing, appraising
[10] and using [11,12] a guideline and its recommenda-
tions. An up-to-date high-quality guideline generally
means that potential biases of guideline development
have been addressed, and that the recommendations are
practicable, reflect the balance between desirable and
undesirable effects, incorporate quality of evidence, con-
sider variability in values of benefits, risks, inconve-
niences, and costs [10-12].
However, although physicians consider guidelines to
be helpful, negative attitudes about the goal of the
guideline, the producers of the guideline, the practicality
of the guideline, as well as controversies and/or incon-
sistencies between guidelines regarding recommenda-
tions, can reduce adherence [13-16]. The reasons for
poor guideline adherence in AGE in children in high-
income countries are unclear, but may be due to incon-
sistency between guideline recommendations, lack of
evidence, and a lack of generalizability of the recom-
mendations to general practice [13].
The aim of the present study is to assess the quality of
international practice guidelines for the management of
acute diarrhea in children in high income countries with
the Appraisal of Guidelines, Research and Evaluation
(AGREE) instrument. We aim to investigate the consis-
tency of the recommendations, evaluate the quality of
evidence and the practicability of these recommenda-
tions to general practice, where most children with AGE
initially present.
Methods
Identification of guidelines
To identify guidelines on acute diarrhea in children,
searches were made in websites of professional societies
in the clinical fields of paediatrics, gastroenterology and
general practice, and websites of institutes involved in
guideline development. On each website we used the
available search technique, searching for diarrhea and/or
gastroenteritis. In addition, a systematic search of the
literature was performed using Medline, Embase, Cinahl
and the Cochrane Library database. The search term
combination captured the concept diarrhea, practice
guidelines and children, using a variety of index terms,
text words and word variants. No limitations were used
(see Appendix 1).
Selection of guidelines
Clinical practice guidelines were defined to be “systema-
tically developed statements to assist practitioner and
patient decisions about appropriate healthcare for speci-
fic clinical circumstances” [17,18]. Selection of articles
was performed using the following pre-defined selection
criteria: i.e. articles were selected if they were: a guide-
line, consensus statement or care protocol on the man-
agement of acute diarrhea in children, and were
produced by a professional organisation (i.e. an organi-
sation that is the official representative of an important
usergroup (paediatricians, gastro-enterologists or general
practitioners). Guidelines were excluded if they were:
opinion based, not designed for children, designed for
low-income countries or exclusively designed for chil-
dren with severe co-morbidities.
Selection of articles was performed by two indepen-
dent researchers. Disagreements about inclusion or
exclusion were resolved by consensus.
Appraisal of guideline quality
The quality of a guideline was assessed using the Apprai-
sal of Guidelines for Research and Evaluation (AGREE)
instrument [10]. The AGREE instrument contains 23
items grouped in six domains - 1/scope and purpose, 2/
stakeholder involvement 3/rigour of development; 4/
clarity and presentation; 5/applicability 6/editorial inde-
pendence - and one overall assessment item, judging
whether the guideline ought to be recommended for its
use in clinical practice. To evaluate each item within the
domains a four-point Likert scale is used, ranging from
strongly disagree to strongly agree (1 to 4). For the over-
all judgment a three-point scale is used ranging from not
recommended to strongly recommended. (See Appendix
2). Two reviewers independently assessed the quality of
each guideline. MB is a general practitioner (GP) and
professor of General Practice at the university hospital
Groningen, JB is a GP and researcher at the Erasmus
MC. After the initial assessment, items with a difference
in score of more than two points were discussed in a
consensus meeting and the scores were adjusted if con-
sensus was reached. Items with a difference in score of
one point were considered to be comparable.
Extraction of recommendations
Data were extracted using a predefined form, covering
the following items: 1) general information: guideline
developers; GP in the development team (yes/no);
method used for assessing the level of evidence, i.e. the
ranking system used to stratify evidence by quality, for
which multiple systems have been developed [19-24], 2)
recommendations: all recommendations for diagnosis
and management with their accompanying level of evi-
dence (LofE), and 3) in order to estimate applicability
for primary care for all evidence used to formulate a
recommendation, study type, setting and population of
each reference were investigated by appraising abstracts
or full-text articles. One researcher (JB) collected the
data and another (MB) verified the data.
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All recommendations were grouped by subject and the
number of guidelines making a recommendation on a
subject was summed. If more than 50% of these guide-
lines made an identical recommendation, the recom-
mendation was considered consistent.
Generalizability to general practice
For recommendations based on published evidence, an
appraisal about the generalizability to general practice
was made. Recommendations were defined as applicable
to general practice if the evidence came from studies in
general practice or an outpatient non-referred popula-
tion. A recommendation was not applicable to general
practice if it was based on evidence emerging from stu-
dies in a hospital setting or a referred population. If evi-
dence came from a mixed population (outpatient as well
as inpatient), it was assessed if a separate analysis was
performed to evaluate differences in outcome between
in- and outpatient populations, if this was not the case,
generalizability was considered inconclusive.
For recommendations based on consensus, recom-
mendations were said to be applicable to general prac-
tice if a GP was involved in guideline development. The
assumption was that the GP would have controlled for
feasibility and applicability of the recommendation in
general practice.
Diagnosis of dehydration
Without predefined definition most guidelines classified
the extent of dehydration differently. Therefore, we
defined three subgroups based on the WHO definition
[25]: no (<3% dehydration), mild-moderate (3-9% dehy-
dration) and severe (>9% dehydration). In accordance
with the classification used in the guideline, the
reviewers assigned signs and symptoms to one of these
categories.
Results
Identification and selection of guidelines
A total of 1,725 titles were found in the search; after
exclusion of duplicates (n = 262) and screening of titles
and abstracts, 62 citations were suitable for full-text eva-
luation. After the initial appraisal, 21 citations were eval-
uated in detail; one additional duplicate was found
[21,25-43]. Nine documents [21,25,30-34,36,37], forming
8 guidelines, met our selection criteria (Figure 1, Table
1).
Guideline characteristics
Table 1 lists the characteristics of the included guide-
lines. A GP was part of the guideline development team
in two guidelines: NICE and NHG.
Guideline quality
The quality of the guidelines was heterogeneous, ranging
from poor to excellent quality (Table 2). The NICE
guideline scored > 50% on all items [33], and the CDC
scored below 40% on all items [30]. All but one guide-
line (CDC) scored high (> = 50%) on clarity and presen-
tation. Lowest scores were given for ‘applicability’
(23.6%). Only the NICE guideline scored high on this
latter item (88.9%). The three guidelines that would not
be recommended by the reviewers scored below 40% on
all items, except clarity and presentation.
Number of recommendations
In total, 242 recommendations on diagnosis and man-
agement were found, of which 138 (57%) were based on
evidence (Table 1). Information upon the number and
the percentage of studies that corroborate for each evi-
dence based recommendation is given in table 3. Five
guidelines used key recommendations [21,30,33,34,37].
The ESPGHAN guideline made the most recommenda-
tions (n = 74), and had the most recommendations that
were based on evidence (n = 47). The CPS had lowest
number of recommendations (n = 17). The WGO
guideline did not state the source of evidence used to
make a recommendation.
Five guidelines stated the LofE of a recommendation.
Four ranking systems for the classification of the LofE
were used. Two ranking systems (CPS and Muir Gray)
combined quality of evidence and strength of the
recommendation in one score containing a number and
a letter. Two ranking systems classified quality of evi-
dence only. Quality of evidence could be classified on a
range of 5 to 12 levels. The best score for quality of evi-
dence was appointed to a systematic review of multiple
well designed RCTs (Scottish guideline, Muir Gray); a
systematic review (CCHMC) or at least one properly
randomized controlled trial (CPS). Because of the het-
erogeneity of the definition of the classes, we refrained
from comparing the outcome of the ranking systems.
Categories of dehydration
Categories of dehydration were defined differently. The
NHG guideline only described the categories ‘no’ and
‘severe’ dehydration. The ESPGHAN guideline encouraged
the use of categories, but did not define how to categorize
dehydration. It did mention, however, the signs for 5%
dehydration, and these signs were placed in our mild-mod-
erate group. The remaining guidelines used categories,
with (WHO, ARM, CCH) or without (WGO and NICE)
percentages, for the extent of dehydration; the signs and
symptoms were placed in our categories accordingly.
Table 3 presents recommendations on diagnosis (signs
and symptoms) and therapy for dehydration. The
van den Berg and Berger BMC Family Practice 2011, 12:134
http://www.biomedcentral.com/1471-2296/12/134
Page 3 of 13consistency of each recommendation is stated, as well as
the setting of the research that was used to form the
recommendation.
Recommendations on the diagnosis of dehydration
There were no recommendations for the diagnosis of
dehydration based on consensus only. All guidelines
provide diagnostic signs/symptoms and relate them to
different categories of dehydration. However, there is a
large variety in the classification of symptoms to the dif-
ferent categories. ‘’Altered mental status’; ‘normal to
increased heart rate’; ‘normal to decreased pulses’; ‘nor-
mal to fast or deep (acidotic) breathing’; ‘sunken eyes’;
‘decreased or absent tears’; ‘dry mucous membranes’;
‘decreased skin pinch’; ‘normal to prolonged capillary
refill’ and ‘warm to cool extremities’ were consistently
related to one of the categories of dehydration. But only
‘decreased skin pinch’ was consistently related to mild-
moderate dehydration in all guidelines. Inconsistent
recommendations were ‘thirst’; ‘decreased urine output’;
‘blood pressure’ and ‘sunken fontanel’.T h es i g n‘normal
to slight increased thirst’ was the only sign consistently
mentioned (in > 50% of guidelines) for the subgroup ‘no
dehydration’. Nine signs were consistently mentioned
for the subgroup ‘mild to moderate dehydration’ and
four signs were consistently mentioned for the subgroup
‘severe dehydration’ (Table 3).
In two guidelines (WGO, CPS), the evidence for the
assigned symptoms for assessing dehydration status is
not stated. Four guidelines (NHG, ESP, NICE, CCH) use
the study of Steiner et al. [44], a meta-analysis on diag-
nostic signs for dehydration. These guidelines comple-
mented their recommendations by using different
additional studies [45-49] (five of which were also
included in the above mentioned meta-analysis) and
existing guidelines [21,25,34,37]. CDC and ARM used
hospital-based cohort studies (both included in the meta-
analysis of Steiner et al.) [45,50] or existing guidelines
[25,51,52]. Only one complementary study, a cohort
study by MacKenzie et al. [45] included in the meta-ana-
lysis of Steiner et al. was used in more than one guideline
(NHG and ARM). All recommendations were based on
research in a hospital setting in referred children, and
therefore not applicable to general practice.
1463
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n = 1291
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Page 4 of 13Table 1 Characteristics of the eight guidelines included in the present study.
Author/Organisation Country of
development
Year of
publication
Intended
users
Level of
evidence
stated?
GP in
development
team?
No. of key
recommendations
No. of recommendations on
diagnosis and management
No. of recommendations
(partly) based on
evidence
Armon, Stephenson, MacFaul 2001
(ARM) [34]
UK 2001 Hospital
care
Yes* No 9 13 8
Centers for Disease Control and
Prevention
(CDC) [25]
USA 2003 Not stated Not stated No Not stated 35 14
European Society for Paediatric
Gastroenterology, Hepatology and
Nutrition
European Society for Paediatric
Infectious Diseases
(ESP) [37]
Europe 2008 All levels of
care
Yes* No 10 74 47
Canadian Paediatric Society
(CPS) [30]
Canada 2006 Not stated Yes
¥ No 9 17 11
World Gastroenterology Organisation
(WGO) [32]
Worldwide 2008 All levels of
care
Not stated No Not stated 21 Not stated
Nederlands huisartsengenootschap
(NHG) [31]
The
Netherlands
2007 General
practitioners
Not stated Yes Not stated 21 15
Cincinnati Children’s Hospital Medical
Center
(CCH) [21]
USA 2006 Hospital
care
Yes
± No 17 26 22
National Institute for Health and
Clinical Excellence
(NICE) [33]
United
Kingdom
2009 All levels of
care
Yes
§ Yes 8 35 21
* Muir-Gray system[19]
¥ System created by the Canadian Taskforce on preventive health [20]
± CCHMC evidence grading scale [21]
§ Scottish guideline development group system [22].
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3Recommendations on management
In total, 22 recommendations on the management of
AGE were made: 14 recommendations were based on
evidence and 8 on consensus. Seven recommendations
based on evidence and 5 based on consensus are consis-
tent. All guidelines, except one (CCH) recommend that
hypo-osmolar rehydration solution should be used to
prevent or treat dehydration (evidence based). Table 4
presents recommendations on ORS dosage. Two guide-
lines, ESP and CCH, did not provide a recommendation
for ORS dosage. The remaining 6 guidelines provide
three consistent recommendations: children with mild-
moderate dehydration should be rehydrated; their
ongoing losses should be replaced; and children with
severe dehydration should be referred to hospital. There
are no consistent recommendations on ORS dosage.
Two recommendations are generalizable to general
practice (NICE and NHG). None of the recommenda-
tions presented in Table 4 are evidence based.
All guidelines state that breastfeeding should be con-
tinued throughout rehydration; an age-appropriate diet
should be started during or after initial rehydration (4-6
hours) and dilution of the formula or the use of a milk-
free formula is unnecessary (evidence based). These
recommendations are based on a review of Brown et al.
[53] and a large number of individual studies. Six guide-
lines state that the use of high-sugar beverages should
be discouraged, six guidelines discourage the use of
antiemetics and six state that antidiarrheals have no
benefit or should not be used (all evidence based)
(Table 3).
For the use of probiotics, the recommendations are
inconsistent. The recommendations are based on 19 dif-
ferent studies and 5 of these studies, all meta-analyses
[54-58], were used by more than one guideline. The sys-
tematic review by Allen et al. [54] was used by 4
guidelines (CCH, ESP, NHG and NICE). Guidelines in
favor of probiotics (CCH, ESP and NHG) base their
recommendations on studies with positive outcomes for
different species of probiotics. The NICE guideline uses
two of the previously mentioned studies [54,57], and
adds studies without a positive result. They conclude
that it is inappropriate to recommend probiotics despite
some evidence for possible benefit. Because the conclu-
sions in reported studies were not consistent and no
separate analyses correcting for study setting (in- or out-
patient) were performed in the meta-analyses used for
the recommendations, the applicability to general prac-
tice remained inconclusive.
One recommendation was based on an outpatient
population and is therefore generalizable to general
practice. For all recommendations based on a mixed
population, no separate analysis correcting for study set-
ting was performed, therefore applicability remains
inconclusive.
Table 5 presents additional recommendations based
on consensus only, and provides information upon the
number and the percentage of studies that corroborate
for each consensus based recommendation. Four guide-
lines (CDC, ESP, NHG, NICE) recommend which
patients should be seen by a physician. Consistent
recommendations were made for the following risk fac-
tors: young age; high output; severe dehydration, persis-
tent vomiting; and signs of severe cause for diarrhea or
underlying disease. A consistent recommendation was
made that blood tests and stool cultures should not be
routinely performed. Six guidelines (Table 5) consis-
tently recommended that a stool culture should be per-
formed in sick patients with dysentery. Six guidelines
consistently recommended that a child needed hospital
reference or admittance, given social/logistic concerns;
failure of initial rehydration; suspected serious
Table 2 Domain scores (in %) after AGREE assessment of the eight guidelines
±
Scope
and purpose
Stakeholder
involvement
Rigour
of development
Clarity
and presentation
Applicability Editorial
independence
Recommend
Guideline*
ARM 100 54.2 88.1 66.7 38.9 50.0 U
CDC 27.7 12.5 35.7 33.3 16.7 8.3 WNR/U
ESP 94.4 37.5 90.5 75.0 11.1 100 SR/R
CPS 16.7 20.8 38.1 70.8 5.6 16.7 WNR
WGO 33.3 33.3 28.6 66.7 16.7 0 WNR
NHG 33.3 25.0 66.7 91.7 11.1 58.3 R
CCH 83.3 57.7 85.7 83.3 0 100 R
NICE 88.9 75.0 88.1 95.8 88.9 100 SR
± Maximum possible score = 100%
* Researchers recommendation for guideline use:
SR = strongly recommend
R = recommend
WNR = would not recommend
U = unsure
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Page 6 of 13Table 3 Assessment of dehydration status and recommendations on therapy.
No dehydration Mild to moderate
dehydration
Severe dehydration Consistent?Yes/
No (№/Total)
Setting
Normal mental status*
#∞§ Normal to altered mental
status*
#∞§±
Normal, altered to comatose mental
status *
#$∞ ± F
Y (7/8) Hospital
± ∞
Normal*
# to slight increase
in thirst
#*
∞$
Thirsty
#∞*$ Greatly increased thirst or drinking
poorly or not at all
$*
#∞
N (4/8) Hospital
∞
Normal to slightly elevated
heart rate
#∞$§
Heart rate normal to increased
#∞$§F
Tachycardia, (with bradycardia in
most severe cases)
#$ ∞§
Y (5/8) Hospital
∞F
Normal pulse quality
#∞§ Quality of pulses normal
§ to
decreased
#∞FΨ
Weak, thready or impalpable
pulses
#∞§
Y (7/8) Hospital
∞FΨ
Normal breathing
∞§ Normal, fast or deep (acidotic
± ) breathing
#§F Ψ
Deep (acidotic
± ) breathing
#F§± Y (5/8) Hospital
FΨ ±
§
No sunken eyes*
#∞§ Sunken eyes
±#∞*$§F (deeply) sunken eyes*
$ ∞#± Y (7/8) Hospital
±
F∞§
Diagnosis Normal/present tears
#∞ Decreased
±#or absent
FΨ
tears
∞
Absent tears
#∞ ± Y (5/8) Hospital
± F∞
Moist
#§ to slightly dry
∞$
mucous membranes
Dry mucous membranes
#±
∞$§F
Very dry mucous membrane
#$ ∞ Y (6/8) Hospital
±
F∞§
Immediate skin pinch*
#§ Skin pinch in 1- 2 seconds
(decreased)
#±*
∞$§FΨ
Very low skin pinch (>2 seconds)*
∞#
$±
Y (8/8) Hospital
Ψ ±
F§
Normal capillary refill
#∞§ Normal
§ to prolonged capillary
refill
#∞FΨ
Prolonged or minimal capillary
refill
#∞§
Y (5/8) Hospital
ΨF§∞
Warm extremities
#§ Warm
§ to cool extremities
#FΨ Cold, mottled or cyanotic
extremities
#$±§
Y (6/8) Hospital
Ψ ± F
Urine output normal
#§ to
slightly decreased
∞$
Decreased urine output
#∞$§ Minimal (to no) urine output
#$∞ N (4/8) Hospital
∞
“No signs”
± Normal blood pressure
∞§ Hypotension/circulatory collapse
$±
∞§
N (4/8) Hospital
∞
Normal anterior fontanel
∞ Sunken anterior fontanel
∞$F Very sunken anterior fontanel
$∞ N (3/8) Hospital
∞F
(Premixed) reduced osmolarity or hypotonic ORS should be used for rehydration*
#$ ± §FΨ Y (7/8) In/outpatient
$± §FΨ
Continue breastfeeding throughout rehydration
F ±§ Ψ$∞ #* Y (8/8) In/outpatient
F ±§ Ψ
Start age-appropriate diet during
∞ or after initial rehydration
F ±§ Ψ$#* Y (7/8) In/outpatient
F ±§ Ψ$∞#
High sugar beverages, canned or carbonated drinks should be avoided
#FΨ$§* Y (6/8) Hospital
§Ψ
Dilution of formula and the use of milk-free formula is unnecessary
F ±§ Ψ$#* Y (7/8) Hospital
§∞Ψ$
Antiemetics are discouraged *
#F∞§Ψ Y (6/8) In/outpatient
Ψ§F
Racedotril is not (yet) recommended
F§# N (3/8) Hospital
F§#
Therapy Racedotril may be useful
∞Ψ N (2/8) Hospital
∞Ψ
Ondansetron is not (yet) recommended
F§# N (3/8) Hospital
F§
Antidiarrheals should not be used/have no benefit*
F∞Ψ§± Y (6/8) In/outpatient
FΨ§ ∇
Zinc supplementation is not (yet) recommended for developed countries
Ψ§# N (3/8) In/outpatient
§Ψ
Probiotics can be used/considered
∞Ψ /do not have to be discouraged
F N (3/8) In/outpatient
∞Ψ F
Probiotics are not recommended
§ N (1/8) In/outpatient
§
Prebiotics are not recommended
Ψ N (1/8) Outpatient
Ψ
** Number of guidelines mentioning this symptom in at least one subgroup
*WGO
# CDC
$CPS
± ARM
∞CCH
FNHG
ΨESP
§ NICE
∇ = research performed in developing countries
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Three guidelines (CDC, CPS, NHG) consistently recom-
mended that vomiting is not a contraindication for
ORT. All other recommendations were not consistent.
For all consistent recommendations based on consen-
sus, a GP was present in guideline development. They
are therefore applicable to patients in general practice.
Discussion
Summary of the findings
Eight guidelines on the management of AGE in children
were evaluated. Based on quality criteria as defined by
the AGREE instrument, the reviewers recommended 4
guidelines for use in daily practice. There is a large vari-
ety in the classification of symptoms to different cate-
gories of dehydration. Of 14 signs and symptoms for
assessing dehydration, ‘decreased skin pinch’ was the
only sign mentioned in all guidelines. None of the signs
were studied in general practice.
It is consistently recommended to use hypo-osmolar
ORS to treat or prevent dehydration. This recommenda-
tion was based on evidence of good quality. The
recommendations regarding ORS dosage, however, are
inconsistent.
Except for probiotics, all recommendations on therapy
are consistent.
Quality of the guidelines
Recommendation for use in daily practice was mostly
influenced by the items ‘rigour of development’, ‘clarity
and presentation’,a n d‘editorial independence’.G u i d e -
lines receiving the highest scores on these items (ESP,
NHG, CCH, NICE) received a ‘recommend’ or ‘strongly
recommend’ rating.
Lowest scores were obtained for the items ‘stakeholder
involvement’ and ‘applicability’.T h i si si na c c o r d a n c e
with the findings of Alonso-Coello et al [59], who per-
formed a systematic review of critical appraisal of guide-
lines in order to evaluate theq u a l i t yo fg u i d e l i n e so v e r
time. They found that ‘stakeholder involvement’ and
‘applicability’ were two of the lowest scoring items of
guidelines in general, and that little improvement was
seen over two decades up to 2007. In contrast with their
findings scores for ‘rigour of development’ were high for
Table 4 Oral rehydration solution (ORS) dosages recommended for each dehydration subgroup.
No dehydration Mild to moderate dehydration Severe
dehydration
Evidence used
Prevention of dehydration:
±§F Rehydration: $*
±§F
￿ 100 ml ORS/kg per 24 h for the 1
st 10 kg of
body weight
±
￿ 30-80 ml ORS/kg/h over 4 hours
±
50 ml/kg/day for the next 10 kg
± ￿ 50-100 ml ORS/kg over 3-4 hours
#*
$
20 ml/kg/day for remaining kg
± ￿ 50 ml ORS/kg over 4 hours
§
￿ 5 ml ORS/kg after each large watery stool
§ ￿ 10-25 ml ORS/kg/hour in 4 hours
F
￿ 10 ml ORS/kg after each large watery stool
F
Maintenance
±§
Ongoing losses:
$#* ￿ 100 ml ORS/kg per 24 h for the 1
st 10 kg of
body weight
￿ ORS
$ 50 ml ORS/kg/day for the next 10 kg Refer to
hospital
No evidence stated for ORS
dosage
$#*
±§F
￿ < 10 kg bodyweight: 60-120 ml ORS for each
stool/vomit
#*
20 ml ORS/kg/day for remaining kg
±
> 10 kg bodyweight: 120-240 ml ORS for each
stool/vomit
#
￿ < 10 kg weight: 100 ml ORS/kg/day
10-20 kg weight: 1000 ml + 50 ml/kg for each
kg > 10
20+kg weight: 1500 ml + 20 ml/kg for each kg
>2 0
§
Ongoing losses:
$#*
§
￿ Replace with ORS
$
￿ 10 ml ORS/kg per stool/vomit
±
￿ < 10 kg bodyweight: 60-120 ml ORS for each
stool/vomit
#*
> 10 kg bodyweight:120-240 ml ORS for each
stool/vomit
#
￿ 5 ml/kg ORS after each large watery stool
§
*WGO
# CDC
$CPS
± ARM
∞CCH
FNHG
ΨESP
§NICE
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Page 8 of 13Table 5 Recommendations on diagnosis and treatment based on consensus.
Guidelines
ARM CDC ESP CPS WGO NHG CCH NICE
AGREE domain score ‘rigour of development’ (%) 88.1 35.7 90.5 38.1 28.6 66.7 85.7 88.1
GP in guideline development team? No No No No No Yes No Yes
DIAGNOSIS Consistent yes/
no
Patients should be seen by physician if: $$ $ $ n=4
#
They have risk factors for dehydration:
Young age + + + Y
￿
Low birth weight/premature birth + + N
Fever ++ N
Stopped breastfeeding +N
High output* + + + + Y
￿
Persistent vomiting/>2 vomits per 24 h + + + Y
￿
Signs of malnutrition +N
Reported signs of severe dehydration + + + Y
￿
Fluid losses exceed intake +N
Not offered/able to tolerate supplemented fluids/suboptimal response + + N
Signs of severe cause for diarrhea/underlying disease + + + + Y
￿
Family circumstances + + N
Blood tests and stool cultures $$ $ $$$$ n=7
#
Should not be routinely performed + + + + + + + Y
￿
Perform stool culture if: $$ $ $$ $ n=6
#
Dehydrated or febrile patients + N
Sick patients with dysentery
¥ ++ + + + Y
￿
Blood/pus in stool + + N
Immuno-compromised patients + + + Y
￿
Patients with high infectivity for others + N
In case of outbreak + N
Recently traveled abroad + + + Y
￿
To verify another etiology/uncertain diagnosis/if no improvement after 7
days
++ N
MANAGEMENT
Refer/admit to hospital if $$ $ $$ $ n=6
#
Social/logistic concerns + + + + + + Y
￿
Failure of initial rehydration + + + + + + Y
￿
Suspected alternative serious diagnosis + + + + + + Y
￿
Shock/severe dehydration + + + + Y
￿
High risk of dehydration + + + N
Intractable/persistent vomiting + N
Vomiting $$ $ n=3
#
is not a contraindication for ORS + + + Y
￿
Do not give ORS if protracted vomiting despite small frequent feeding + N
§ : Guidelines making a recommendation on this subject
* = > 6 diarrheal stool in 24 h, or > 3 vomits in 24 h or watery diarrhea > 6 times a day > 3 days (<2 years: > 1 day)
¥ Dysentery = diarrhea with mucus and/or blood in stool, with fever and abdominal pain
# = number of guidelines making a recommendation on this subject
+ = recommended
￿ = a general practitioner was present in at least one guideline production
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Page 9 of 13four of the guidelines we evaluated. Two of these were
published after 2007 [33,37]. Alonso-Coello et al argue,
that this domain may be the strongest indicator for
quality, therefore our finding might indicate that some
improvement on guideline development can be seen.
Further improvement on stakeholder involvement and
applicability as well as rigour of development might
make guidelines for management of acute gastroenteritis
in children more trustworthy to the user, and could
improve guideline adherence.
Quality of evidence
Three guidelines did not state the ranking system for
the classification of the LofE of a recommendation. In
addition, it was an intriguing finding that the evidence
for a comparable recommendation could differ between
guidelines, and vice versa that the recommendations
could vary despite the same evidence. Quality of the evi-
dence is an important indication for the strength of a
recommendation, and should be consistently measured.
We assume that non-adherence might be explained by
the lack of consensus about quality of evidence, one of
the most important indicators for the strength of a
recommendation.
But obviously quality of evidence is not the only deter-
minant of the strength of a recommendation. According
to the GRADE Working Group[60,61], four key factors
determine the strength of a recommendation: balance
between desirable and undesirable effects; quality of evi-
dence; values and preferences of the team, and costs.
These additional arguments might have explained the
heterogeneity between the recommendations. None of
the guidelines, however, mentioned additional argu-
ments that influenced their recommendations.
A uniform ranking system for the classification of the
strength of recommendations is needed to make guide-
line-use more comprehensible and therewith increases
adherence.
Recommendations on diagnosis
The recommendations on signs related to dehydration
are consistent, whereas the classification of signs in cate-
gories of dehydration is not. Even though hospital based
evidence might, to some degree, be used for general
practice, the generalizability of the recommendations for
general practice is suboptimal. As a consequence, it
remains unclear which signs are most important for
classifying the extent of deh y d r a t i o ni nac h i l dw i t h
AGE, and to decide which child should be referred or
admitted to a hospital.
Recommendations on management
The recommended ORS regimen for each category of
dehydration differed between guidelines. Possible
reasons for this heterogeneity are the differences in cut-
off points defining categories of dehydration, and the
fact that expert opinions rather then evidence was used
to formulate recommendations. As for now the optimal
ORS regimen remains unclear.
The recommendations on prescribing probiotics are
inconsistent and are evidently subject to interpretation
by the guideline team. Only two guidelines (NHG,
NICE) provide arguments for their interpretation of the
available evidence, and conclude that there is insufficient
evidence for recommendations on probiotics.
For none of the recommendations based on a mixed
population it could be assessed if the study setting influ-
enced the outcome, nor was this difference discussed in
any guideline. For the guideline user, generalizability to
general practice remains unknown.
Limitations of the review
Appraisal of quality was performed by two reviewers,
where preferably four appraisers are needed. Because we
specifically wanted to review the guidelines from the
perspective of the GP and both appraisers were GPs,
ánd because the ranges of scores were small, we feel
another two GPs would not give more precise or valid
estimates of quality. Even though a thorough search of
possible guidelines was performed, the possibility
remains that we missed a guideline. We assumed that if
a recommendation was based on consensus, because evi-
dence was lacking, the presence of a GP gave the best
available indication that applicability, and balance
between benefit and harm had been evaluated from the
perspective of the GP. We realise that this assumption
is disputable.
Conclusion
The present systematic review shows considerable varia-
tion in the quality of guidelines on AGE in children, as
well as considerable inconsistencies between the recom-
mendations. In 43% the quality of the evidence could
not be interpreted because no level of evidence was sta-
ted and most recommendations are not generalizable to
general practice. Although we know that ORT should
be given, it remains unclear ‘how’ or to ‘whom’;t h i s
may explain why adherence to treatment is currently
suboptimal.
This study reveals implications for further research.
Future studies, particularly in general practice, need to
determine the value of clinical signs and symptoms in
assessing dehydration. Second, the optimal ORS dosage
for each grade of dehydration should be established, so
that consistent recommendations can be made. Third,
we need to investigate the considerations of clinicians to
prescribe medication to children with AGE, and assess
whether these considerations are valid. Finally, a
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Page 10 of 13uniform grading system, such as the GRADE system,
should be used to grade the strength of guideline
recommendations.
Appendix 1
Search strings databases and researched websites
Pubmed
((child OR infant) OR ("Child"[Mesh]) OR ("Infant"[-
Mesh])) AND ((((guideline) OR (practice guideline) OR
(consensus development) OR (recommendations)) OR
("Guideline “[Publication Type])) AND ((diarrhea OR
diarr*) OR (("Diarrhea"[Mesh]) OR
("Gastroenteritis"[Mesh]))))
Embase
(’diarrhea’/exp OR ‘gastroenteritis’/exp OR gastroen-
teritis OR diarrhea) AND (guideline OR ‘practice guide-
line’/exp OR consensus OR ‘consensus’/exp OR
recommendations) AND (child or ‘child’/exp)
Cochrane
("Diarrhea"[Mesh]) OR ("Gastroenteritis"[Mesh]) AND
guideline
Cinahl
((MH “Practice Guidelines”) or guideline or practice
guideline or recommendation or consensus) AND ((MH
“Diarrhea”)o r( M H“Gastroenteritis”) or diarrhea or
gastroenteritis or diarr*) AND ((MH “Child”) or child)
Websites: (diarrhea and/or gastroenteritis)
￿ http://www.guideline.gov (National Guideline
Clearinghouse)
￿ http://www.tripdatabase.com (TRIP database)
￿ http://www.cma.ca (Canadian Medical Association)
￿ http://www.worldgastroenterology.org (World Gas-
troenterology Organisation)
￿ http://nhg.artsennet.nl/home.htm (Nederlands Hui-
sartsen Genootschap)
￿ http://www.aap.org (American Academy of
Pediatrics)
￿ http://www.who.int (World Health Organization)
￿ http://www.cdc.gov (Centers for Disease Control
and Prevention)
￿ http://www.pediatriconcall.com
￿ http://www.library.nhs.uk (National Library for
Health)
￿ http://www.emedicine.medscape.com
￿ http://www.childhealthfoundation.org (Child
Health Foundation)
￿ http://www.racgp.org.au (The Royal Australian
College of General Practitioners)
￿ http://www.rcgp.org.uk (Royal College of General
Practitioners)
￿ http://www.nice.org.uk (National Institute for
Health and Clinical Excellence)
￿ http://www.sign.ac.uk (Scottish Intercollegiate
Guidelines Network (SIGN)
￿ http://clinicalevidence.bmj.com (BMJ Clinical
Evidence)
￿ www.gfmer.ch (Geneva Foundation for Medical
Education and Research)
￿ http://www.acponline.org (American College of
Physicians)
￿ http://www.nzgg.org.nz/ (New Zealand Guidelines
Group)
￿ www.cbo.nl (kwaliteitsinstituut voor de
gezondheidszorg)
￿ www.nvk.pedianet.nl (Nederlandse Vereniging voor
kindergeneeskunde)
￿ http://www.espghan.org (European Society for Pea-
diatric Gastroenterology, Hepatology and Nutrition
￿ http://www.g-i-n.net
Appendix 2
The AGREE instrument is used to asses the quality of
reporting and the quality of recommendations of a
guideline. Quality is assessed on 23 items in six
domains: scope and purpose; stakeholder involvement;
rigour of development; clarity and presentation; applic-
ability and editorial independence. A score for each
item, ranging from 1 (strongly disagree) to 4 (strongly
agree) is given by each appraiser after which a standar-
dised domain score is calculated by summing all the
scores of the individual items in a domain, and by stan-
dardising the total as a percentage of the maximum pos-
sible score for that domain. An overall assessment leads
to recommendations for use of the appraised guideline.
For further information, see http://www.agreetrust.org
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AGE: Acute Gastroenteritis; AGREE: Appraisal of Guidelines for Research and
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